A. Athanassiou

639 total citations
33 papers, 479 citations indexed

About

A. Athanassiou is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Athanassiou has authored 33 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Athanassiou's work include Ovarian cancer diagnosis and treatment (7 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). A. Athanassiou is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). A. Athanassiou collaborates with scholars based in Greece and United Kingdom. A. Athanassiou's co-authors include Dimitrios Pectasides, J. Varthalitis, D. Pectasides, Maria V. Papadopoulou, L. Gogou, V. Barbounis, Faye Antoniou, A. Visvikis, P. Kosmidis and Nikolaos Ziras and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Annals of Oncology.

In The Last Decade

A. Athanassiou

32 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Athanassiou Greece 14 194 191 110 103 92 33 479
Sameera Rashid Qatar 8 80 0.4× 167 0.9× 126 1.1× 83 0.8× 66 0.7× 21 435
D. Paraïso France 14 216 1.1× 272 1.4× 149 1.4× 96 0.9× 401 4.4× 35 689
William Crabtree United States 13 373 1.9× 188 1.0× 224 2.0× 142 1.4× 130 1.4× 29 753
Poonam Vohra United States 13 160 0.8× 181 0.9× 108 1.0× 162 1.6× 48 0.5× 56 545
Kumiko Nakazawa Japan 10 311 1.6× 204 1.1× 119 1.1× 106 1.0× 24 0.3× 18 493
A Balaton France 10 127 0.7× 174 0.9× 108 1.0× 92 0.9× 25 0.3× 28 413
Walter M. Klein United States 9 120 0.6× 325 1.7× 171 1.6× 74 0.7× 29 0.3× 13 568
Patricia C. Ewing‐Graham Netherlands 13 192 1.0× 137 0.7× 122 1.1× 74 0.7× 106 1.2× 39 528
Kyung Ran Park South Korea 13 189 1.0× 283 1.5× 50 0.5× 144 1.4× 19 0.2× 24 595
W. Jäger Germany 13 44 0.2× 172 0.9× 118 1.1× 41 0.4× 107 1.2× 40 407

Countries citing papers authored by A. Athanassiou

Since Specialization
Citations

This map shows the geographic impact of A. Athanassiou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Athanassiou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Athanassiou more than expected).

Fields of papers citing papers by A. Athanassiou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Athanassiou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Athanassiou. The network helps show where A. Athanassiou may publish in the future.

Co-authorship network of co-authors of A. Athanassiou

This figure shows the co-authorship network connecting the top 25 collaborators of A. Athanassiou. A scholar is included among the top collaborators of A. Athanassiou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Athanassiou. A. Athanassiou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trafalis, Dimitrios T., et al.. (2012). Preclinical evaluation of the homo-aza-steroid ester 13beta-hydroxy-13alpha-amino-13,17- seco-5alpha-androstan-17-oic-13,17-lactam-p-bis(2-chloroethyl)aminophenoxy acetate for the treatment of malignant melanoma.. PubMed. 8(4). 333–9. 5 indexed citations
2.
Grivas, Anastasios, Dimitrios T. Trafalis, & A. Athanassiou. (2009). Implication of bevacizumab in fatal arterial thromboembolic incidents.. PubMed. 14(1). 115–7. 6 indexed citations
3.
Tsiambas, Evangelos, Andreas Karameris, Stavros Gourgiotis, et al.. (2007). Simultaneous deregulation of p16 and cyclin D1 genes in pancreatic ductal adenocarcinoma: a combined immunohistochemistry and image analysis study based on tissue microarrays.. PubMed. 12(2). 261–7. 6 indexed citations
4.
Pectasides, D., et al.. (2002). Weekly chemotherapy with docetaxel, gemcitabine and cisplatin in advanced transitional cell urothelial cancer: a phase II trial. Annals of Oncology. 13(2). 243–250. 39 indexed citations
5.
Pectasides, D., et al.. (2002). Weekly chemotherapy with carboplatin, docetaxel and irinotecan in advanced non-small-cell-lung cancer. European Journal of Cancer. 38(9). 1194–1200. 13 indexed citations
6.
Pectasides, Dimitrios, et al.. (2000). Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trial. European Journal of Cancer. 36(1). 74–79. 22 indexed citations
7.
Pectasides, D., et al.. (1998). Paclitaxel in Cisplatin or Carboplatin-Pretreated Ovarian Cancer. Oncology. 55(3). 228–234. 8 indexed citations
8.
9.
Triposkiadis, F., et al.. (1998). Left atrial systolic function is depressed in idiopathic and preserved in ischemic dilated cardiomyopathy. Journal of the American College of Cardiology. 31. 149–149. 2 indexed citations
10.
Pectasides, Dimitrios, et al.. (1997). CEA, CA 19-9, and CA-50 in Monitoring Gastric Carcinoma. American Journal of Clinical Oncology. 20(4). 348–353. 69 indexed citations
11.
Pectasides, Dimitrios, Faye Antoniou, L. Gogou, et al.. (1996). TPA, TATI, CEA, AFP, β-HCG, PSA, SCC, and CA 19-9 for Monitoring Transitional Cell Carcinoma of the Bladder. American Journal of Clinical Oncology. 19(3). 271–277. 54 indexed citations
12.
Pectasides, Dimitrios, et al.. (1995). Chemotherapy for Merkel Cell Carcinoma with Carboplatin and Etoposide. American Journal of Clinical Oncology. 18(5). 418–420. 34 indexed citations
13.
Pectasides, Dimitrios, et al.. (1994). Treatment of Primary Fallopian Tube Carcinoma with Cisplatin-Containing Chemotherapy. American Journal of Clinical Oncology. 17(1). 68–71. 21 indexed citations
14.
Pectasides, Dimitrios, et al.. (1994). Adjuvant Chemotherapy With Dacarbazine, Vindesine, and Cisplatin in Pathological Stage II Malignant Melanoma. American Journal of Clinical Oncology. 17(1). 55–59. 11 indexed citations
15.
Pectasides, D., et al.. (1992). Cerebrovascular Accidents Following Hormonochemotherapy in Cancer Patients. American Journal of Clinical Oncology. 15(2). 168–173. 2 indexed citations
16.
Pectasides, Dimitrios, et al.. (1992). Cisplatin-containing regimen in advanced or recurrent granulosa cell tumours of the ovary. Annals of Oncology. 3(4). 316–318. 23 indexed citations
17.
Pectasides, D., et al.. (1991). Correlation of Abdominal Computed Tomography Scanning and Second-Look Operation Findings in Ovarian Cancer Patients. American Journal of Clinical Oncology. 14(6). 457–462. 24 indexed citations
18.
Athanassiou, A., et al.. (1990). 131I-labelled monoclonal antibody H17E2 in the detection of subcutaneous metastasis from gestational choriocarcinoma.. PubMed. 10(4). 913–5. 2 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sameera Rashid Breakdown of academic impact, for papers by D. Paraïso Breakdown of academic impact, for papers by William Crabtree Breakdown of academic impact, for papers by Poonam Vohra Breakdown of academic impact, for papers by Kumiko Nakazawa Breakdown of academic impact, for papers by A Balaton Breakdown of academic impact, for papers by Walter M. Klein Breakdown of academic impact, for papers by Patricia C. Ewing‐Graham Breakdown of academic impact, for papers by Kyung Ran Park Breakdown of academic impact, for papers by W. Jäger
Rankless by CCL
2026